BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27350054)

  • 1. Deepening uncertainty on how the EU may regulate supposable endocrine disruptors.
    Gori GB; Dekant W
    Regul Toxicol Pharmacol; 2016 Nov; 81():8-9. PubMed ID: 27350054
    [No Abstract]   [Full Text] [Related]  

  • 2. Whither the impending european regulation of presumed endocrine disruptors?
    Autrup HN; Berry SC; Cohen SM; Creppy EE; de Camargo JL; Dekant W; Dietrich D; Galli CL; Goodman JI; Gori GB; Greim HA; Klaunig JE; Lotti M; Marquardt HW; Wallace KB; Yamazaki H
    Regul Toxicol Pharmacol; 2016 Dec; 82():A1-A2. PubMed ID: 27615676
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulating endocrine disruptors linked to cancer.
    Burki TK
    Lancet Oncol; 2019 May; 20(5):e246. PubMed ID: 30930025
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern.
    Bars R; Fegert I; Gross M; Lewis D; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):143-54. PubMed ID: 22735369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles.
    Dietrich DR; von Aulock S; Marquardt H; Blaauboer B; Dekant W; Kehrer J; Hengstler J; Collier A; Gori GB; Pelkonen OP; Lang F; Nijkamp FP; Stemmer K; Li A; Savolainen K; Hayes A; Gooderham N; Harvey A
    Toxicol In Vitro; 2013 Oct; 27(7):2110-4. PubMed ID: 23850741
    [No Abstract]   [Full Text] [Related]  

  • 6. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles.
    Dietrich DR; von Aulock S; Marquardt H; Blaauboer B; Dekant W; Kehrer J; Hengstler J; Collier A; Gori GB; Pelkonen O; Lang F; Nijkamp FP; Stemmer K; Li A; Savolainen K; Hayes AW; Gooderham N; Harvey A
    Food Chem Toxicol; 2013 Dec; 62():A1-4. PubMed ID: 23835284
    [No Abstract]   [Full Text] [Related]  

  • 7. Revising the EU strategy on endocrine disruptors: nearing a decisive moment.
    van Vliet L; Jensen GK
    J Epidemiol Community Health; 2013 May; 67(5):383-4. PubMed ID: 23144491
    [No Abstract]   [Full Text] [Related]  

  • 8. EU safety regulations: Don't mar legislation with pseudoscience.
    Dietrich DR
    Nature; 2016 Jul; 535(7612):355. PubMed ID: 27443732
    [No Abstract]   [Full Text] [Related]  

  • 9. Endocrine Society seeks better testing to determine endocrine disruptor health risks.
    Mitka M
    JAMA; 2012 Aug; 308(6):556-7. PubMed ID: 22871851
    [No Abstract]   [Full Text] [Related]  

  • 10. EU regulation of endocrine disruptors: a missed opportunity.
    Kortenkamp A; Bourguignon JP; Slama R; Bergman Å; Demeneix B; Ivell R; Panzica G; Trasande L; Zoeller RT
    Lancet Diabetes Endocrinol; 2016 Aug; 4(8):649-650. PubMed ID: 27377541
    [No Abstract]   [Full Text] [Related]  

  • 11. Science and policy on endocrine disrupters must not be mixed: a reply to a "common sense" intervention by toxicology journal editors.
    Bergman Å; Andersson AM; Becher G; van den Berg M; Blumberg B; Bjerregaard P; Bornehag CG; Bornman R; Brandt I; Brian JV; Casey SC; Fowler PA; Frouin H; Giudice LC; Iguchi T; Hass U; Jobling S; Juul A; Kidd KA; Kortenkamp A; Lind M; Martin OV; Muir D; Ochieng R; Olea N; Norrgren L; Ropstad E; Ross PS; Rudén C; Scheringer M; Skakkebaek NE; Söder O; Sonnenschein C; Soto A; Swan S; Toppari J; Tyler CR; Vandenberg LN; Vinggaard AM; Wiberg K; Zoeller RT
    Environ Health; 2013 Aug; 12():69. PubMed ID: 23981490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precautionary principle for toxic chemicals - no alternative to safeguard societal benefits.
    Jostmann T
    Hum Exp Toxicol; 2007 Nov; 26(11):847-9; discussion 875-6. PubMed ID: 18042578
    [No Abstract]   [Full Text] [Related]  

  • 13. The precautionary principle: is it a threat to toxicological science?
    Goldstein BD
    Int J Toxicol; 2006; 25(1):3-7. PubMed ID: 16510351
    [No Abstract]   [Full Text] [Related]  

  • 14. Science based guidance for the assessment of endocrine disrupting properties of chemicals.
    Bars R; Broeckaert F; Fegert I; Gross M; Hallmark N; Kedwards T; Lewis D; O'Hagan S; Panter GH; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):37-46. PubMed ID: 20858523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An appeal for the integrity of science and public policy.
    Toxicology; 2016 Sep; 371():1-11. PubMed ID: 27600434
    [No Abstract]   [Full Text] [Related]  

  • 16. Principles and practices of health risk assessment under current EU regulations.
    Rudén C
    Regul Toxicol Pharmacol; 2006 Feb; 44(1):14-23. PubMed ID: 16188358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EU-ToxRisk method documentation, data processing and chemical testing pipeline for the regulatory use of new approach methods.
    Krebs A; van Vugt-Lussenburg BMA; Waldmann T; Albrecht W; Boei J; Ter Braak B; Brajnik M; Braunbeck T; Brecklinghaus T; Busquet F; Dinnyes A; Dokler J; Dolde X; Exner TE; Fisher C; Fluri D; Forsby A; Hengstler JG; Holzer AK; Janstova Z; Jennings P; Kisitu J; Kobolak J; Kumar M; Limonciel A; Lundqvist J; Mihalik B; Moritz W; Pallocca G; Ulloa APC; Pastor M; Rovida C; Sarkans U; Schimming JP; Schmidt BZ; Stöber R; Strassfeld T; van de Water B; Wilmes A; van der Burg B; Verfaillie CM; von Hellfeld R; Vrieling H; Vrijenhoek NG; Leist M
    Arch Toxicol; 2020 Jul; 94(7):2435-2461. PubMed ID: 32632539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data gaps threaten chemical safety law.
    Gilbert N
    Nature; 2011 Jul; 475(7355):150-1. PubMed ID: 21753825
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of endocrine-disrupting chemicals: critical overview and deficiencies in toxicology and risk assessment for human health.
    Harvey PW; Everett DJ
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):145-65. PubMed ID: 16522525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health risk assessment procedures for endocrine disrupting compounds within different regulatory frameworks in the European Union.
    Beronius A; Rudén C; Hanberg A; Håkansson H
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):111-22. PubMed ID: 19500631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.